EP2207879A4 - Identification and isolation of fetal cells and nucleic acid - Google Patents
Identification and isolation of fetal cells and nucleic acidInfo
- Publication number
- EP2207879A4 EP2207879A4 EP08831741A EP08831741A EP2207879A4 EP 2207879 A4 EP2207879 A4 EP 2207879A4 EP 08831741 A EP08831741 A EP 08831741A EP 08831741 A EP08831741 A EP 08831741A EP 2207879 A4 EP2207879 A4 EP 2207879A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- isolation
- identification
- nucleic acid
- fetal cells
- fetal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97439207P | 2007-09-21 | 2007-09-21 | |
PCT/US2008/077251 WO2009039507A2 (en) | 2007-09-21 | 2008-09-22 | Identification and isolation of fetal cells and nucleic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2207879A2 EP2207879A2 (en) | 2010-07-21 |
EP2207879A4 true EP2207879A4 (en) | 2011-01-26 |
Family
ID=40468814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08831741A Withdrawn EP2207879A4 (en) | 2007-09-21 | 2008-09-22 | Identification and isolation of fetal cells and nucleic acid |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2207879A4 (en) |
JP (1) | JP2010539906A (en) |
KR (1) | KR20100061539A (en) |
CN (1) | CN101883851A (en) |
AU (1) | AU2008302040A1 (en) |
BR (1) | BRPI0817199A2 (en) |
CA (1) | CA2699958A1 (en) |
IL (1) | IL204585A0 (en) |
MX (1) | MX2010003116A (en) |
NZ (1) | NZ584165A (en) |
WO (1) | WO2009039507A2 (en) |
ZA (1) | ZA201001912B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8476013B2 (en) * | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US20120100538A1 (en) | 2009-03-24 | 2012-04-26 | Biocept, Inc. | Devices and methods of cell capture and analysis |
WO2010111388A2 (en) | 2009-03-24 | 2010-09-30 | Biocept, Inc. | Devices and methods of cell capture and analysis |
DK2516680T3 (en) | 2009-12-22 | 2016-05-02 | Sequenom Inc | Method and kits to identify aneuploidy |
EP4155401A1 (en) * | 2012-03-02 | 2023-03-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
CA2876692C (en) | 2012-06-22 | 2022-05-24 | Quantrx Biomedical Corporation | Method for obtaining fetal cells and fetal cellular components |
US20140093873A1 (en) | 2012-07-13 | 2014-04-03 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11155805B2 (en) | 2017-03-27 | 2021-10-26 | Sekisui Medical Co., Ltd. | Target nucleic acid concentration and recovery method using antibody |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007121276A2 (en) * | 2006-04-12 | 2007-10-25 | Biocept, Inc. | Enrichment of circulating fetal dna |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026417A1 (en) * | 1994-03-29 | 1995-10-05 | Genzyme Corporation | Culture and isolation of fetal cells from maternal peripheral blood |
EP1483415A4 (en) * | 2002-02-20 | 2006-02-01 | Univ Virginia | A non-invasive diagnostic test utilizing histone modification markers |
GB0211904D0 (en) * | 2002-05-23 | 2002-07-03 | Medical Res Council | Nuclear transfer |
US20050181429A1 (en) * | 2003-04-03 | 2005-08-18 | Monaliza Medical Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
US20040197832A1 (en) * | 2003-04-03 | 2004-10-07 | Mor Research Applications Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
-
2008
- 2008-09-22 NZ NZ584165A patent/NZ584165A/en not_active IP Right Cessation
- 2008-09-22 MX MX2010003116A patent/MX2010003116A/en unknown
- 2008-09-22 WO PCT/US2008/077251 patent/WO2009039507A2/en active Application Filing
- 2008-09-22 AU AU2008302040A patent/AU2008302040A1/en not_active Abandoned
- 2008-09-22 CA CA2699958A patent/CA2699958A1/en not_active Abandoned
- 2008-09-22 BR BRPI0817199-8A2A patent/BRPI0817199A2/en not_active IP Right Cessation
- 2008-09-22 JP JP2010526048A patent/JP2010539906A/en active Pending
- 2008-09-22 CN CN2008801087518A patent/CN101883851A/en active Pending
- 2008-09-22 EP EP08831741A patent/EP2207879A4/en not_active Withdrawn
- 2008-09-22 KR KR1020107008140A patent/KR20100061539A/en not_active Application Discontinuation
-
2010
- 2010-03-17 ZA ZA2010/01912A patent/ZA201001912B/en unknown
- 2010-03-18 IL IL204585A patent/IL204585A0/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007121276A2 (en) * | 2006-04-12 | 2007-10-25 | Biocept, Inc. | Enrichment of circulating fetal dna |
Also Published As
Publication number | Publication date |
---|---|
IL204585A0 (en) | 2010-11-30 |
ZA201001912B (en) | 2011-05-25 |
BRPI0817199A2 (en) | 2014-10-14 |
CA2699958A1 (en) | 2009-03-26 |
MX2010003116A (en) | 2010-08-03 |
EP2207879A2 (en) | 2010-07-21 |
JP2010539906A (en) | 2010-12-24 |
AU2008302040A1 (en) | 2009-03-26 |
WO2009039507A2 (en) | 2009-03-26 |
WO2009039507A3 (en) | 2009-06-18 |
NZ584165A (en) | 2012-09-28 |
CN101883851A (en) | 2010-11-10 |
KR20100061539A (en) | 2010-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL204585A0 (en) | Identification and isolation of fetal cells and nucleic acid | |
GB0701253D0 (en) | Nucleic acid amplification and testing | |
GB0814570D0 (en) | Isolation of nucleic acid | |
IL214034A0 (en) | Single -cell nucleic acid analysis | |
EP2356259A4 (en) | Products and processes for multiplex nucleic acid identification | |
HK1171083A1 (en) | Nucleic acid analysis | |
EP2229457A4 (en) | Gender-specific separation of sperm cells and embryos | |
EP2242857A4 (en) | Method for isolating cell free apoptotic or fetal nucleic acids | |
EP2414545A4 (en) | Nucleic acid preparation compositions and methods | |
EP2207896A4 (en) | Nucleic acid amplification | |
EP2310524A4 (en) | Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids | |
GB0910302D0 (en) | Nucleic acid amplification | |
IL217370A (en) | Nucleic acid prodrugs and methods of use thereof | |
PL2254698T3 (en) | Mobile device for the isolation of nucleic acid | |
PT3375891T (en) | Methods and devices for compensation of spectral crosstalk in multiplex nucleic acid amplification | |
EP2115123A4 (en) | Selective lysis of sperm cells | |
EP2481800A4 (en) | Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof | |
ZA201102195B (en) | Methods and compositions for isolating nucleic acid | |
HK1118859A1 (en) | Nucleic acid isolation using polidocanol and derivatives | |
EP2344619A4 (en) | System for identification of multiple nucleic acid targets in a single sample and use thereof | |
GB0812862D0 (en) | Nucleic acid amplification | |
PL2248913T3 (en) | GNLY as epigenetic marker for the identification of CD56-expressing natural killer cells | |
EP2300488A4 (en) | Cell lysis reagent for isolation of rna | |
EP2333059A4 (en) | Universal nucleic acid probe set and method for utilization thereof | |
EP2195453A4 (en) | Method of amplifying nucleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100414 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20101230 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/09 20060101AFI20090416BHEP Ipc: C07K 16/28 20060101ALI20101222BHEP Ipc: G01N 33/53 20060101ALI20101222BHEP Ipc: C12Q 1/68 20060101ALI20101222BHEP Ipc: G01N 33/50 20060101ALI20101222BHEP Ipc: G01N 33/68 20060101ALI20101222BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1146544 Country of ref document: HK |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20140507 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140918 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1146544 Country of ref document: HK |